Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease (CHD-NIRS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01679275 |
Recruitment Status : Unknown
Verified May 2018 by Universitaire Ziekenhuizen Leuven.
Recruitment status was: Active, not recruiting
First Posted : September 5, 2012
Last Update Posted : July 16, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Heart Defects, Congenital | Other: measuring cerebral oxygenation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Longitudinal Pre-operative Measurements of Cerebral Oxygenation Using Near Infrared Spectroscopy in Neonates With Congenital Heart Disease. |
Study Start Date : | October 2012 |
Actual Primary Completion Date : | June 2018 |
Estimated Study Completion Date : | December 2019 |

Arm | Intervention/treatment |
---|---|
measuring cerebral oxygenation
NIRS: Measurement of cerebral oxygenation using Near Infrared Spectroscopy (NIRS) during the pre-operative phase in neonates with congenital heart disease.
|
Other: measuring cerebral oxygenation |
- Neurodevelopmental follow up at 24 months [ Time Frame: 24 months ]Neurodevelopmental assessment at 24 months using Bayley scales of infant development II

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 1 Month (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- neonates with admission on neonatal intensive care unit with congenital heart disease.
Exclusion Criteria:
- No informed consent.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01679275
Belgium | |
Neonatal Intensive Care Unit UZLeuven | |
Leuven, Vlaams Brabant, Belgium, 3000 |
Principal Investigator: | Liesbeth Thewissen, MD | UZ Leuven |
Responsible Party: | Universitaire Ziekenhuizen Leuven |
ClinicalTrials.gov Identifier: | NCT01679275 |
Other Study ID Numbers: |
S54683 |
First Posted: | September 5, 2012 Key Record Dates |
Last Update Posted: | July 16, 2018 |
Last Verified: | May 2018 |
Heart Defects, congenital Patient Monitoring Infant, Newborn Physiology |
Heart Diseases Heart Defects, Congenital Congenital Abnormalities Cardiovascular Diseases Cardiovascular Abnormalities |